GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
FOXC2 | hg19_v2_chr16_+_86600857_86600921 | -0.14 | 3.4e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr17_-_26695013 Show fit | 11.45 |
ENST00000555059.2
|
Homeobox protein SEBOX |
|
chr17_-_26694979 Show fit | 11.37 |
ENST00000438614.1
|
vitronectin |
|
chr11_-_116708302 Show fit | 10.42 |
ENST00000375320.1
ENST00000359492.2 ENST00000375329.2 ENST00000375323.1 |
apolipoprotein A-I |
|
chr11_+_62186498 Show fit | 8.86 |
ENST00000278282.2
|
secretoglobin, family 1A, member 1 (uteroglobin) |
|
chr12_-_92539614 Show fit | 8.83 |
ENST00000256015.3
|
B-cell translocation gene 1, anti-proliferative |
|
chr17_-_39684550 Show fit | 8.01 |
ENST00000455635.1
ENST00000361566.3 |
keratin 19 |
|
chr10_+_71561649 Show fit | 6.61 |
ENST00000398978.3
ENST00000354547.3 ENST00000357811.3 |
collagen, type XIII, alpha 1 |
|
chr4_-_174256276 Show fit | 6.20 |
ENST00000296503.5
|
high mobility group box 2 |
|
chr14_-_36988882 Show fit | 5.94 |
ENST00000498187.2
|
NK2 homeobox 1 |
|
chr17_+_72426891 Show fit | 5.76 |
ENST00000392627.1
|
G protein-coupled receptor, family C, group 5, member C |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 19.6 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
1.6 | 14.3 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 11.7 | GO:0006936 | muscle contraction(GO:0006936) |
2.6 | 10.4 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
1.5 | 8.9 | GO:0010193 | response to ozone(GO:0010193) |
0.7 | 8.8 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.5 | 8.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
1.1 | 8.0 | GO:0008218 | bioluminescence(GO:0008218) |
0.2 | 8.0 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
1.6 | 7.8 | GO:0021759 | globus pallidus development(GO:0021759) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 23.2 | GO:0005615 | extracellular space(GO:0005615) |
4.9 | 19.6 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
3.6 | 14.3 | GO:0071062 | rough endoplasmic reticulum lumen(GO:0048237) alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.9 | 12.9 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 12.8 | GO:0072562 | blood microparticle(GO:0072562) |
1.8 | 10.6 | GO:1990357 | terminal web(GO:1990357) |
3.5 | 10.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.1 | 9.4 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 8.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.7 | 6.6 | GO:0005579 | membrane attack complex(GO:0005579) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 23.8 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 13.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.5 | 12.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 11.6 | GO:0003712 | transcription cofactor activity(GO:0003712) |
2.6 | 10.4 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.6 | 10.0 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
1.5 | 8.9 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 8.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.6 | 8.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.2 | 7.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 25.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.4 | 19.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.3 | 18.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.5 | 15.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 11.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 10.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 9.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 6.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 6.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 5.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 19.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 19.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.3 | 16.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.6 | 15.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 10.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 8.8 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.3 | 6.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 6.5 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 5.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 5.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |